Filter Results:
(555)
Show Results For
- All HBS Web
(555)
- People (1)
- News (225)
- Research (228)
- Events (1)
- Multimedia (11)
- Faculty Publications (146)
Show Results For
- All HBS Web
(555)
- People (1)
- News (225)
- Research (228)
- Events (1)
- Multimedia (11)
- Faculty Publications (146)
- May 1999 (Revised December 2007)
- Case
The Dana-Farber Cancer Institute: Development Strategy
By: V. Kasturi Rangan and Marie Bell
Despite revenues in excess of $93 million in 1998, world-renowned Dana-Farber Cancer Institute constantly faces an operating shortfall and looks to its highly successful development office to help cover the deficit. The development office raises money annually (with a... View Details
Keywords: Decision Choices and Conditions; Capital; Revenue; Growth and Development Strategy; Mission and Purpose; Nonprofit Organizations
Rangan, V. Kasturi, and Marie Bell. "The Dana-Farber Cancer Institute: Development Strategy." Harvard Business School Case 599-104, May 1999. (Revised December 2007.)
- May 2016
- Article
How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
By: Stephen M. Schleicher, Nancy M. Wood, Seohyun Lee and Thomas W. Feeley
The Patient Protection and Affordable Care Act (ACA), passed in 2010, contained a number of provisions with potential to directly or indirectly affect cancer care. Value for patients was widely discussed throughout the bill, and the Centers for Medicare and Medicaid... View Details
Schleicher, Stephen M., Nancy M. Wood, Seohyun Lee, and Thomas W. Feeley. "How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?" Oncology 30, no. 5 (May 2016): 468–474.
- 12 Jan 2017
- News
What Cancer Researchers Can Learn from Direct-to-Consumer Companies
- 21 Jun 2017
- News
A New Approach to Safely Sharing Cancer Patients’ Data
- 11 Jan 2017
- News
How do we solve the crisis in cancer communication?
- 12 Feb 2019
- News
4 Important Steps to Take After a Cancer Diagnosis
- 2024
- Working Paper
Tamoxifen—Reducing Breast Cancer Risks: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
We describe the development of tamoxifen, considered a “gold standard” treatment for
millions of breast cancer patients. Specifically, we describe breast cancer treatments before tamoxifen’s
development; the initial development of tamoxifen from 1960 to 1973;... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation and Invention; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Tamoxifen—Reducing Breast Cancer Risks: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-134, July 2020. (Revised May 2024.)
- September 2011
- Article
A Cancer Center Puts the New Approach to Work: Pilot
By: Heidi W. Albright and Thomas W. Feeley
The University of Texas MD Anderson Cancer Center is a National Cancer Institute–designated Comprehensive Cancer Center, located in Houston, Texas. Seeing more than 30,000 new patients every year, MD Anderson accounts for approximately 20% of
cancer care within the... View Details
Keywords: Health Care; Health Care Quality; Measurement; Costing; Accounting; Health; Quality; Health Industry; North and Central America
Albright, Heidi W., and Thomas W. Feeley. "A Cancer Center Puts the New Approach to Work: Pilot." R1109B. Harvard Business Review 89, no. 9 (September 2011): 15–16. (This article is a sidebar description of a pilot of time-driven activity-based costing in the HBR article "How to Solve the Cost Crisis in Health Care" by Robert S. Kaplan and Michael E. Porter.)
- February 2003 (Revised August 2003)
- Teaching Note
Dana-Farber Cancer Institute, The (TN)
By: Richard M.J. Bohmer
Teaching Note for (9-699-025). View Details
Keywords: Health Industry
- November 2012 (Revised February 2009)
- Teaching Note
The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care (TN)
By: Michael E. Porter and Sachin H Jain
Teaching Note for [708487]. View Details
Porter, Michael E., and Sachin H Jain. "The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care (TN)." Harvard Business School Teaching Note 709-482, February 2009. (Revised from original February 2009 version.)
- February 2010
- Teaching Note
Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan (TN)
By: Michael E. Porter and Jennifer F Baron
Teaching Note for [710425]. View Details
- March 2014
- Article
Delivering High-quality Cancer Care: The Critical Role of Quality Measurement
By: Tracy Spinks, Patricia Ganz, George Sledge, Laura Levit, James Hayman, Timothy Eberlein and Thomas W. Feeley
In 1999, the Institute of Medicine (IOM) published Ensuring Quality Cancer Care, an influential report that described an ideal cancer care system and issued ten recommendations to address pervasive gaps in the understanding and delivery of quality cancer... View Details
Keywords: Health Care Quality; Health Care and Treatment; Quality; Measurement and Metrics; Health Industry; North America
Spinks, Tracy, Patricia Ganz, George Sledge, Laura Levit, James Hayman, Timothy Eberlein, and Thomas W. Feeley. "Delivering High-quality Cancer Care: The Critical Role of Quality Measurement." Healthcare: The Journal of Delivery Science and Innovation 2, no. 1 (March 2014): 53–62. (PMCID: PMC4021589.)
- 05 Sep 2017
- News
Bargaining With Cancer Patients About Treatment
- December 2011 (Revised December 2011)
- Case
Cancer Treatment Centers of America: Scaling the Mother Standard of Care
By: Rosabeth Moss Kanter and Matthew Bird
The CEO of a private and growing national network of specialty care hospitals focusing on advanced-stage and complex cancer treatments reflected on the firm's past phase of growth before meeting with the company's Chairman and founder to discuss how to further scale... View Details
Keywords: Health Care and Treatment; Business Growth and Maturation; Medical Specialties; Service Delivery; Innovation and Invention; Health Industry
Kanter, Rosabeth Moss, and Matthew Bird. "Cancer Treatment Centers of America: Scaling the Mother Standard of Care." Harvard Business School Case 312-073, December 2011. (Revised December 2011.)
- 15 Mar 2019
- News
Targeting cancer and careers: Precision Medicine
- 12 Dec 2018
- News
Impact Investing Could Accelerate the Fight Against Cancer
- August 17, 2016
- Article
How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures
By: Kevin P. Shah, Tracy E. Spinks and Thomas W. Feeley
In 2014, The University of Texas MD Anderson Cancer Center created a streamlined process for developing measure sets for patient-centered outcomes, including provider-generated and patient-reported outcomes, at an accelerated pace. These comprehensive sets are... View Details
Keywords: Information Technology; Measurement and Metrics; Quality; Service Delivery; Health Care and Treatment; Health Industry; Texas
Shah, Kevin P., Tracy E. Spinks, and Thomas W. Feeley. "How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures." NEJM Catalyst (August 17, 2016).
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
her work that last spring he presented the MMRF with a $4.8 million gift to further its pathbreaking cancer research. Commented HBS professor Bill Sahlman, who introduced Bowes and Giusti, “Their collaboration shows how HBS alumni can and... View Details
- July 2011 (Revised September 2012)
- Case
Intraoperative Radiotherapy for Breast Cancer (A)
By: Willy Shih
"This trial is going to take longer." Those were words that Michael Kaschke, CEO of Carl Zeiss AG, was not surprised to hear as he nurtured the intraoperative radiotherapy business inside his company's microsurgery unit. But he also didn't expect it to take 13 years to... View Details
Keywords: Finance; Business History; Disruptive Innovation; Emerging Markets; Organizational Change and Adaptation; Research and Development; Safety
Shih, Willy. "Intraoperative Radiotherapy for Breast Cancer (A)." Harvard Business School Case 612-003, July 2011. (Revised September 2012.)